---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-027090"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T13:47:08.421869+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Dogwood Therapeutics shareholders approve warrant exercise for up to 4.4M shares

## Summary
- Proposal to approve potential exercise of warrant for 4,386,037 shares passed with 29,286,786 votes for, 19,057 against, 4,466 abstentions.
- Approval required under Securities Purchase Agreement dated Jan 11, 2026 and Nasdaq Listing Rule 5635(d).
- Adjournment proposal also approved with 29,283,790 for, 21,571 against.
- Quorum of 29,310,309 shares (88.03% of voting power) present at Special Meeting held March 11, 2026.

## SEC filing metadata
- accession: 0001104659-26-027090
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000110465926027090/0001104659-26-027090-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000110465926027090/dwtx-20260311x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-027090
- JSON: https://secwatch.observer/filing/0001104659-26-027090.json
- Plain text: https://secwatch.observer/filing/0001104659-26-027090.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.